ArticleCureus2025
Pituitary Stalk Interruption Syndrome: A Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pituitary stalk interruption syndrome (PSIS) is a rare congenital endocrine condition characterized by a developmental anomaly of the pituitary gland, leading to deficiencies in anterior pituitary hormones due to the absence or underdevelopment of the pituitary stalk and anterior pituitary gland. An ectopic posterior pituitary; anterior pituitary hypoplasia or aplasia; and a thin, interrupted, or missing pituitary stalk constitute the classic triad of symptoms that define PSIS. PSIS is manifested in various forms and may be identified at different stages of life. PSIS may present as an isolated growth hormone deficiency occurring due to the deficiency of multiple pituitary hormones. Although the exact aetiology remains unknown, genetic mutations are considered a potential causative factor for disease onset. Hormone replacement therapy and early detection of PSIS are essential for preventing long-term consequences. Here, we report three cases in which patients at different stages of life presented with a wide variety of clinical manifestations of PSIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.